nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—CCL2—age related macular degeneration	0.992	1	CbGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—TIMP3—age related macular degeneration	0.000713	0.0941	CbGpPWpGaD
Danazol—CCL2—Ectoderm Differentiation—ELOVL4—age related macular degeneration	0.000484	0.0639	CbGpPWpGaD
Danazol—CCL2—IL-1 signaling pathway—SQSTM1—age related macular degeneration	0.000361	0.0476	CbGpPWpGaD
Danazol—ESR1—LKB1 signaling events—MAP2—age related macular degeneration	0.000299	0.0395	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—REST—age related macular degeneration	0.000241	0.0319	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.000232	0.0306	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.000227	0.0299	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—CRP—age related macular degeneration	0.000188	0.0249	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.000176	0.0233	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—SKIV2L—age related macular degeneration	0.000169	0.0222	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—B3GLCT—age related macular degeneration	0.000169	0.0222	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.000161	0.0213	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00015	0.0198	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—RHO—age related macular degeneration	0.000139	0.0183	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.000139	0.0183	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—RHO—age related macular degeneration	0.000134	0.0177	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—RHO—age related macular degeneration	0.000123	0.0162	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—RHO—age related macular degeneration	0.000119	0.0158	CbGpPWpGaD
Danazol—PGR—Validated nuclear estrogen receptor alpha network—C3—age related macular degeneration	0.000117	0.0155	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TLR4—age related macular degeneration	0.000113	0.015	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.000109	0.0143	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—RHO—age related macular degeneration	0.000107	0.0141	CbGpPWpGaD
Danazol—AR—Notch-mediated HES/HEY network—KDR—age related macular degeneration	0.000104	0.0138	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—VEGFA—age related macular degeneration	0.000101	0.0133	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	9.44e-05	0.0125	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—C3—age related macular degeneration	8.5e-05	0.0112	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—TGFBR1—age related macular degeneration	7.79e-05	0.0103	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	7.19e-05	0.0095	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—RHO—age related macular degeneration	6.94e-05	0.00916	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—RHO—age related macular degeneration	6.89e-05	0.0091	CbGpPWpGaD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—C3—age related macular degeneration	6.87e-05	0.00907	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TGFBR1—age related macular degeneration	6.71e-05	0.00885	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—RDH8—age related macular degeneration	6.64e-05	0.00877	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	6.46e-05	0.00853	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—RHO—age related macular degeneration	6.3e-05	0.00832	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—RDH8—age related macular degeneration	6.08e-05	0.00802	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TGFBR1—age related macular degeneration	6e-05	0.00793	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	5.9e-05	0.00778	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—RPE65—age related macular degeneration	5.81e-05	0.00767	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	5.7e-05	0.00753	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	5.54e-05	0.00732	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—RPE65—age related macular degeneration	5.31e-05	0.00701	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	5.22e-05	0.00689	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CCL2—age related macular degeneration	5.01e-05	0.00661	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	4.98e-05	0.00657	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ABCA4—age related macular degeneration	4.68e-05	0.00618	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	4.5e-05	0.00594	CbGpPWpGaD
Danazol—PGR—Gene Expression—ERCC6—age related macular degeneration	4.47e-05	0.0059	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—C3—age related macular degeneration	4.34e-05	0.00573	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ABCA4—age related macular degeneration	4.28e-05	0.00565	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	4.08e-05	0.00539	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—RHO—age related macular degeneration	4.07e-05	0.00537	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—C3—age related macular degeneration	3.97e-05	0.00524	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RDH8—age related macular degeneration	3.83e-05	0.00506	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—RHO—age related macular degeneration	3.72e-05	0.00492	CbGpPWpGaD
Danazol—AR—Gene Expression—ERCC6—age related macular degeneration	3.4e-05	0.00449	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RPE65—age related macular degeneration	3.35e-05	0.00442	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CCL2—age related macular degeneration	3.11e-05	0.0041	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NMNAT1—age related macular degeneration	3e-05	0.00397	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ABCA4—age related macular degeneration	2.7e-05	0.00356	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ELOVL4—age related macular degeneration	2.63e-05	0.00347	CbGpPWpGaD
Danazol—ESR1—Gene Expression—ERCC6—age related macular degeneration	2.62e-05	0.00346	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	2.43e-05	0.00321	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RHO—age related macular degeneration	2.35e-05	0.0031	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	2.35e-05	0.0031	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFBR1—age related macular degeneration	2.29e-05	0.00302	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	2.26e-05	0.00298	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RDH8—age related macular degeneration	2.25e-05	0.00297	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—C3—age related macular degeneration	2.24e-05	0.00296	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—C3—age related macular degeneration	2.23e-05	0.00294	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	2.2e-05	0.0029	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SLC16A8—age related macular degeneration	2.12e-05	0.00279	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFBR1—age related macular degeneration	2.09e-05	0.00276	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SQSTM1—age related macular degeneration	2.07e-05	0.00274	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—C3—age related macular degeneration	2.04e-05	0.00269	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RPE65—age related macular degeneration	1.97e-05	0.00259	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	1.94e-05	0.00256	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SQSTM1—age related macular degeneration	1.9e-05	0.0025	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	1.87e-05	0.00247	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	1.74e-05	0.00229	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CCL2—age related macular degeneration	1.59e-05	0.00211	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ABCA4—age related macular degeneration	1.58e-05	0.00209	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	1.44e-05	0.0019	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	1.41e-05	0.00186	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RHO—age related macular degeneration	1.38e-05	0.00182	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFBR1—age related macular degeneration	1.32e-05	0.00174	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—C3—age related macular degeneration	1.32e-05	0.00174	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	1.24e-05	0.00164	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APOE—age related macular degeneration	1.23e-05	0.00162	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—C3—age related macular degeneration	1.2e-05	0.00159	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KDR—age related macular degeneration	1.2e-05	0.00159	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SQSTM1—age related macular degeneration	1.2e-05	0.00158	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APOE—age related macular degeneration	1.12e-05	0.00148	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KDR—age related macular degeneration	1.1e-05	0.00145	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—LIPC—age related macular degeneration	1.08e-05	0.00143	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CETP—age related macular degeneration	1.05e-05	0.00138	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCL2—age related macular degeneration	9.42e-06	0.00124	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	8.77e-06	0.00116	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFBR1—age related macular degeneration	7.74e-06	0.00102	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	7.66e-06	0.00101	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—C3—age related macular degeneration	7.59e-06	0.001	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOE—age related macular degeneration	7.07e-06	0.000933	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SQSTM1—age related macular degeneration	7.01e-06	0.000926	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KDR—age related macular degeneration	6.92e-06	0.000914	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—age related macular degeneration	6.61e-06	0.000873	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CD36—age related macular degeneration	6.28e-06	0.000829	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	6.18e-06	0.000815	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—age related macular degeneration	6.05e-06	0.000799	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCL2—age related macular degeneration	5.94e-06	0.000784	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOE—age related macular degeneration	5.54e-06	0.000732	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—C3—age related macular degeneration	4.46e-06	0.000588	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOE—age related macular degeneration	4.15e-06	0.000548	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KDR—age related macular degeneration	4.06e-06	0.000537	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—age related macular degeneration	3.81e-06	0.000504	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL2—age related macular degeneration	3.49e-06	0.00046	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LIPC—age related macular degeneration	3.16e-06	0.000417	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CETP—age related macular degeneration	3.05e-06	0.000403	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—age related macular degeneration	2.24e-06	0.000296	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CD36—age related macular degeneration	1.83e-06	0.000242	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOE—age related macular degeneration	1.62e-06	0.000213	CbGpPWpGaD
